about
A novel nonsense variant in Nav1.5 cofactor MOG1 eliminates its sodium current increasing effect and may increase the risk of arrhythmiasNew population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants.Mutations in genes encoding cardiac ion channels previously associated with sudden infant death syndrome (SIDS) are present with high frequency in new exome data.New population-based exome data question the pathogenicity of some genetic variants previously associated with Marfan syndrome.Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol.Brugada syndrome risk loci seem protective against atrial fibrillation.Common and rare variants in SCN10A modulate the risk of atrial fibrillation.Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover studyLong-Term Exposure to Traffic-Related Air Pollution and Risk of Incident Atrial Fibrillation: A Cohort Study.High-sensitivity C-reactive protein and exercise-induced changes in subjects suspected of coronary artery disease.Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS).Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol.Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke.Mild Hypokalemia and Supraventricular Ectopy Increases the Risk of Stroke in Community-Dwelling Subjects.Excessive Atrial Ectopy and Short Atrial Runs Increase the Risk of Stroke Beyond Incident Atrial Fibrillation.Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study.Residential exposure to traffic noise and risk of incident atrial fibrillation: A cohort study.Long-term prognostic significance of homocysteine in middle-aged and elderly.The circadian variation of premature atrial contractions.Ambulatory cardiac arrhythmias in relation to mild hypokalaemia and prognosis in community dwelling middle-aged and elderly subjects.Temporal pattern of the effect of verapamil on myocardial reinfarction. DAVIT Study Group. Danish Verapamil Infarction Trial.Diagnosing left ventricular hypertrophy in arterial hypertension.Rare variants in GJA5 are associated with early-onset lone atrial fibrillation.Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease.Genetic modifier of the QTc interval associated with early-onset atrial fibrillation.Mild hyponatremia carries a poor prognosis in community subjects.A new combination therapy in stable angina pectoris.Modest weight loss in moderately overweight postmenopausal women improves heart rate variability.Serum Potassium Is Positively Associated With Stroke and Mortality in the Large, Population-Based Malmö Preventive Project Cohort.Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.Decreased nighttime heart rate variability is associated with increased stroke risk.Liraglutide effects on beta-cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes.Troponin T and N-terminal pro B-Type natriuretic peptide and presence of coronary artery disease.Increased ventricular ectopic activity in relation to C-reactive protein, and NT-pro-brain natriuretic peptide in subjects with no apparent heart disease.Prognostic Impact of Mild Hypokalemia in Terms of Death and Stroke in the General Population-A Prospective Population Study.Comparison of the prognosis after early versus late recurrent nonfatal myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial.[The use of vena cava filters in Denmark].Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial.Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial.[Diagnosis of acute myocardial infarction in Denmark]
P50
Q24304891-FEA2F30F-A0FA-43AE-A1F2-9FC806A3D082Q30585171-14AA7EA2-B4B3-489F-A671-1F83332F8C59Q30596838-499C75C3-1C21-4D94-A940-0F834DF0B615Q31166327-32FE13B5-9DC9-4E82-8195-BFE74609AF45Q34477722-A4CC3E20-A7AA-4A41-B6AE-2E384072B7B6Q34508291-79EDDEE1-9213-443F-8E3C-1E6E69F1F802Q35352846-C28C668D-C727-493E-B1A9-B3D5483077E9Q37125983-E03377CA-A28A-4E6D-8203-4BFFA272E975Q37674960-C54447F9-631E-4520-9714-AEB7FFF905E0Q37688165-84DD8338-07E7-433D-987B-67F96CE3AC4CQ38389279-A1F589E5-46A9-49B0-9865-829BDD81C044Q39754261-11A36A14-A093-4F30-B857-747373B7B0DDQ39929393-2DD21158-40D8-4660-8592-58404724CE9BQ40345599-05B499BA-3D5B-4371-9F23-3FF5F4C86DC4Q40726281-50EFEC32-E406-49D9-8397-772CDB85D3EEQ40747277-E4F7A09F-296B-4082-B776-808223A0D168Q40761462-09CC661B-A2F3-48A5-ACD2-A9CB4579A32EQ40836256-1B3C8647-8787-4B36-95AD-E66F42143BFEQ41020450-EC4814A9-83B0-4520-AB7D-AC6A67761860Q41465336-D51437AB-B43B-4C05-9E1B-FB17E257B6D5Q42538105-5A750792-B786-43E7-999A-B537EAF23364Q42539395-2940DDDD-C8FE-4219-86FB-9BC4D37D5FFBQ44317102-C6D3E539-F815-4205-A4DF-34836F5A0F17Q44806693-FCBBE454-9D5D-46A8-8F83-F6635273B701Q45161931-F41287DC-F214-403E-8BED-01C734E4C338Q45950574-2B9F06DE-0ADC-4680-91BD-B960F74B640FQ46133345-5AA88110-BE58-49E6-80F0-080E3F203A27Q47318934-4B1A12D9-8C0B-4702-858F-35004C64755AQ48034929-92AEF2BA-8761-433B-96CD-D716284F953AQ48261655-52C214F0-2733-4445-B44E-2230CBF877F0Q48282786-EFBE6933-3860-4DC1-8CD6-BFAAB39C746BQ48309227-51CEEC28-D8DE-4CFF-A120-063257CD2453Q48356073-545F4300-E660-4FE4-9FB2-5AD94804C818Q48372335-FDB60EF2-F303-427F-A012-FDF5065D0F2FQ50099483-0503DD27-2B80-4B07-B663-9BCE9FBBF69EQ50561936-D8147337-F26F-457A-B417-D827438F2FFEQ50562436-9C603311-795E-4668-BF80-2ACD9318C981Q50563067-4E0DBF68-7977-4E5F-8874-729C5472DB24Q50563212-E55D67AC-DF9B-4868-AAB7-16C8BFDCC7E7Q50564651-D2CCB4A5-F699-442C-8FF9-3C7D7BD3DA23
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Ahmad Sajadieh
@ast
Ahmad Sajadieh
@en
Ahmad Sajadieh
@es
Ahmad Sajadieh
@nl
Ahmad Sajadieh
@sl
type
label
Ahmad Sajadieh
@ast
Ahmad Sajadieh
@en
Ahmad Sajadieh
@es
Ahmad Sajadieh
@nl
Ahmad Sajadieh
@sl
prefLabel
Ahmad Sajadieh
@ast
Ahmad Sajadieh
@en
Ahmad Sajadieh
@es
Ahmad Sajadieh
@nl
Ahmad Sajadieh
@sl
P108
P214
P106
P21
P214
P31
P496
0000-0001-5463-9860
P7859
viaf-307272414